tirzepatide vs topiramate Updated Meta-Analysis of Obesity Medications in The BMJ | Michael Weintraub, MD posted on the topic What are the differences between

39 Conclusion In particular, as Asians have less -cell functional capacity compared with Caucasians, the importance of prevention and timely treatment strategy for T2DM aiming to preserve or recover functional -cell mass should be emphasized in the Asian population

Gallbladder disease , including cholecystitis and cholelithiasis, has been reported more frequently in patients taking weight loss injections compared to placebo

Yagoda N, von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, Fridman DJ et al (2007) RASRAFMEK-dependent oxidative cell death involving voltage-dependent anion channels

Short follow-up periods may not capture potential safety issues associated with long-term use, thereby increasing the unknown risks to the long-term health of pediatric patients